Alkeon Capital Reduces Stake in Astera Labs by 37.5%

Alkeon Capital Management LLC has decreased its ownership in Astera Labs, Inc. (NASDAQ: ALAB) by 37.5% during the third quarter of 2023. According to a recent disclosure to the Securities and Exchange Commission, the firm sold 150,000 shares, leaving it with a total of 250,000 shares valued at approximately $48.95 million.

This reduction in shares comes amidst a backdrop of activity from other institutional investors. For instance, Clearstead Advisors LLC increased its holdings in Astera Labs by 13.6% during the same period, now owning 636 shares worth about $125,000 following an acquisition of 76 additional shares. Similarly, Great Valley Advisor Group Inc. raised its stake by 2.2%, bringing its total to 4,119 shares valued at $372,000.

Rye Brook Capital LLC also reported an increase, with a 1.1% boost in holdings for a total of 9,200 shares valued at roughly $1.80 million. Notably, Assetmark Inc. significantly ramped up its stake by 374.1%, now holding 128 shares worth $25,000. Finally, SlateStone Wealth LLC raised its ownership by 1.3%, resulting in 12,744 shares valued at $2.50 million. Overall, institutional investors now control 60.47% of Astera Labs’ stock.

Astera Labs Performance and Earnings

Astera Labs shares opened at $120.31 recently, showing volatility with a one-year low of $47.13 and a high of $262.90. The company has a market capitalization of $20.48 billion and a price-to-earnings (PE) ratio of 98.61. The firm reported strong earnings on February 10, 2023, with earnings per share (EPS) of $0.58, surpassing the consensus estimate of $0.51 by $0.07.

Revenue for the quarter reached $270.58 million, exceeding analyst expectations of $249.46 million. This marks a significant year-on-year increase of 91.8%, compared to the same period last year when earnings were $0.37 per share. Looking ahead, Astera Labs has set its guidance for Q1 2026 at $0.530-$0.540 EPS, with analysts forecasting an EPS of $0.34 for the current year.

Insider Trading Activity

In related news, insider trading activity has also been notable. General Counsel Philip Mazzara sold 10,000 shares on March 2, 2023, at an average price of $117.47, totaling $1,174,700. After this transaction, Mazzara owned 128,084 shares valued at $15.05 million, reflecting a 7.24% decrease in ownership.

Additionally, Chief Financial Officer Michael Truett Tate sold 12,001 shares on February 17, 2023, at an average price of $123.81, amounting to $1,485,843.81. Post-transaction, Tate retained 192,083 shares valued at $23.78 million, a 5.88% decrease from his previous holdings. Overall, insiders have sold 224,292 shares in the last quarter, valued at $27.68 million, with insiders holding 12.50% of the stock.

Analysts’ Ratings and Future Outlook

Several brokerages have recently provided ratings for Astera Labs. BNP Paribas Exane initiated coverage on November 20, 2023, assigning an “outperform” rating. Morgan Stanley reaffirmed its “overweight” rating with a target price of $210.00 on December 3, 2023. Similarly, Royal Bank of Canada issued an “outperform” rating with a target price of $225.00 on January 14, 2024.

In contrast, Weiss Ratings downgraded the stock from “hold (c-)” to “sell (d+)” on February 23, 2024. Meanwhile, Barclays established a price objective of $165.00 on January 15, 2024. Collectively, fifteen investment analysts have rated the stock as a Buy, while six have assigned a Hold rating, and one has rated it as a Sell. The overall consensus indicates a “Moderate Buy” with an average target price of $202.22.

Astera Labs, a fabless semiconductor company, specializes in developing connectivity solutions tailored for data centers and cloud infrastructures. The firm’s focus is on addressing signal integrity and link management challenges associated with the integration of high-bandwidth processors and accelerators in server architectures. Its technology aims to enhance the reliability and performance of high-speed interconnects utilized in servers, storage systems, and compute accelerators.

The company’s diverse product range encompasses silicon devices as well as accompanying firmware and software, designed to optimize and manage high-speed links, positioning Astera Labs as a significant player in the semiconductor industry.